Article Details

C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Average Recommendation of "Buy" from Analysts

Retrieved on: 2021-09-07 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Average Recommendation of "Buy" from Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 2,632,424 shares of the company's stock worth $99,610,000 after purchasing an additional 1,437,932 shares during the period. Vanguard ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up